These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30396082)

  • 1. DPP-4 inhibitor impedes lipopolysaccharide-induced osteoclast formation and bone resorption in vivo.
    Ishida M; Shen WR; Kimura K; Kishikawa A; Shima K; Ogawa S; Qi J; Ohori F; Noguchi T; Marahleh A; Kitaura H
    Biomed Pharmacother; 2019 Jan; 109():242-253. PubMed ID: 30396082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (D-Ala
    Lin A; Kitaura H; Ohori F; Noguchi T; Marahleh A; Ma J; Ren J; Miura M; Fan Z; Narita K; Mizoguchi I
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 Inhibits Lipopolysaccharide-Induced Osteoclast Formation and Bone Resorption via Inhibition of TNF-
    Shen WR; Kimura K; Ishida M; Sugisawa H; Kishikawa A; Shima K; Ogawa S; Qi J; Kitaura H
    J Immunol Res; 2018; 2018():5783639. PubMed ID: 29725604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-X-C Motif Chemokine 12 Enhances Lipopolysaccharide-Induced Osteoclastogenesis and Bone Resorption In Vivo.
    Shima K; Kimura K; Ishida M; Kishikawa A; Ogawa S; Qi J; Shen WR; Ohori F; Noguchi T; Marahleh A; Kitaura H
    Calcif Tissue Int; 2018 Oct; 103(4):431-442. PubMed ID: 29845409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous Angiotensin-(1-7) Provides Protection Against Inflammatory Bone Resorption and Osteoclastogenesis by Inhibition of TNF-α Expression in Macrophages.
    Ren J; Kitaura H; Noguchi T; Ohori F; Marahleh A; Ma J; Kanou K; Fan Z; Mizoguchi I
    Calcif Tissue Int; 2024 Oct; 115(4):432-444. PubMed ID: 39030433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-37 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption in vivo.
    Saeed J; Kitaura H; Kimura K; Ishida M; Sugisawa H; Ochi Y; Kishikawa A; Takano-Yamamoto T
    Immunol Lett; 2016 Jul; 175():8-15. PubMed ID: 27154248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azilsartan inhibits inflammation-triggered bone resorption and osteoclastogenesis
    Fan Z; Kitaura H; Ren J; Ohori F; Noguchi T; Marahleh A; Ma J; Kanou K; Miura M; Narita K; Lin A; Mizoguchi I
    Front Endocrinol (Lausanne); 2023; 14():1207502. PubMed ID: 37795376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors.
    Strålberg F; Kassem A; Kasprzykowski F; Abrahamson M; Grubb A; Lindholm C; Lerner UH
    J Leukoc Biol; 2017 May; 101(5):1233-1243. PubMed ID: 28196851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docosahexaenoic Acid Inhibits Inflammation-Induced Osteoclast Formation and Bone Resorption
    Kishikawa A; Kitaura H; Kimura K; Ogawa S; Qi J; Shen WR; Ohori F; Noguchi T; Marahleh A; Nara Y; Ichimura A; Mizoguchi I
    Front Endocrinol (Lausanne); 2019; 10():157. PubMed ID: 30949128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locally administered interferon-γ accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation.
    Ayon Haro ER; Ukai T; Yokoyama M; Kishimoto T; Yoshinaga Y; Hara Y
    J Periodontal Res; 2011 Jun; 46(3):361-73. PubMed ID: 21361961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo.
    Kimura K; Kitaura H; Fujii T; Hakami ZW; Takano-Yamamoto T
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):219-27. PubMed ID: 22067001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
    Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
    Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.
    Ohyama Y; Ito J; Kitano VJ; Shimada J; Hakeda Y
    PLoS One; 2018; 13(1):e0191192. PubMed ID: 29342179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-33 Inhibits TNF-α-Induced Osteoclastogenesis and Bone Resorption.
    Ohori F; Kitaura H; Ogawa S; Shen WR; Qi J; Noguchi T; Marahleh A; Nara Y; Pramusita A; Mizoguchi I
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.
    Ishida M; Kitaura H; Kimura K; Sugisawa H; Aonuma T; Takada H; Takano-Yamamoto T
    J Immunol Res; 2015; 2015():132765. PubMed ID: 26000311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
    Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
    Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wogonin inhibits osteoclast formation induced by lipopolysaccharide.
    Jang S; Bak EJ; Kim M; Kim JM; Chung WY; Cha JH; Yoo YJ
    Phytother Res; 2010 Jul; 24(7):964-8. PubMed ID: 19998398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W; Bar-Shavit Z
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival.
    Ochi H; Hara Y; Tagawa M; Shinomiya K; Asou Y
    J Orthop Res; 2010 May; 28(5):657-63. PubMed ID: 19890995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.